Results 201 to 210 of about 31,914 (284)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta-analysis of controlled randomized trials. [PDF]

J Arrhythm
Chang TY, Chan YH, Chao TF, Lin CY, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP, Chen SA.   +9 more
europepmc   +1 more source

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants. [PDF]

J Chest Surg, 2023
Heo M, Jeong DS, Chung S, Park KM, Park SJ, On YK.   +5 more
europepmc   +1 more source

Renal function decline in Asian patients with atrial fibrillation with warfarin and non-vitamin K antagonist oral anticoagulants: A report from the COOL-AF registry. [PDF]

J Arrhythm
Krittayaphong R, Treewaree S, Yindeengam A, Lip GYH.   +3 more
europepmc   +1 more source

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. [PDF]

Open Heart, 2023
Joosten LPT, van Maanen R, van den Dries CJ, Rutten FH, Hoes AW, Granger CB, Hemels MEW, Geersing GJ, van Doorn S.   +8 more
europepmc   +1 more source

Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management. [PDF]

Interv Cardiol
Izraiq M, Alshoubaki N, Abu-Dhaim OA, Aqel R.   +3 more
europepmc   +1 more source

Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation. [PDF]

Eur Heart J Suppl, 2022
Giugliano RP.
europepmc   +1 more source

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial

American Heart Journal, 2017
P. Kirchhof, Benjamin Blank, M. Calvert, J. Camm, G. Chlouverakis, H. Diener, A. Goette, Andrea Huening, G. Lip, E. Simantirakis, P. Vardas   +10 more
semanticscholar   +1 more source

Combination of non-vitamin K antagonist oral anticoagulants and antiepileptic drugs

European Heart Journal, 2019
Semiha, Kurt, Orhan, Sumbul, Durdane, Aksoy   +2 more
openaire   +2 more sources

Safety of Non-vitamin K Antagonist Oral Anticoagulants on Outcomes After Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis. [PDF]

Cureus
Goyal A, Khan Suheb M, Saeed H, Changez MIK, Tariq MD, Shah V, Abbasi FQ, Fatima L, Jain H, Senapati SG, Borra V.   +10 more
europepmc   +1 more source

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease. [PDF]

Eur Heart J Suppl, 2022
Fanaroff AC, Vora AN, Lopes RD.
europepmc   +1 more source